|
Guidelines for the Use of Antiretroviral Agents in HIV-Infected
Adults and Adolescents
These Guidelines were developed by the Panel on Clinical Practices
for Treatment of HIV Infection convened by the Department of Health
and Human Services (DHHS) and the Henry J. Kaiser Family Foundation.
Leadership of the Panel consists of Anthony S. Fauci, National Institutes
of Health, Bethesda, MD (co-chair); John G. Bartlett, Johns Hopkins
University, Baltimore, MD (co-chair); Eric P. Goosby, DHHS, Washington,
DC, (co-convener); and Jennifer Kates, Henry J. Kaiser Foundation,
San Francisco, CA, (co-convener).
Current members of the Panel include: Jean Anderson (Johns Hopkins
University, Baltimore, MD), Rodney Armstead (UHP Healthcare, Inc.,
Inglewood, CA), A. Cornelius Baker (Whitman-Walker
Clinic, Washington, DC), David Barr (Forum for Collaborative
HIV Research, Washington, DC), Samuel A. Bozzette (SDVA Medical
Center, San Diego, CA), Charles Carpenter (Brown University School
of Medicine, Providence, RI), Martin Delaney (Project Inform,
San Francisco, CA), Lawrence Deyton, (Dept.
of Veterans Affairs, Washington, DC), Wafaa El-Sadr (Harlem
Hospital, New York, NY), Courtney Fletcher
(University of Minnesota, MN), Fred Gordin, (Veterans Administration
Medical Center, Washington, DC), Mark Harrington (Treatment Action
Group, New York, NY), Martin S. Hirsch (Massachusetts General Hospital,
Boston, MA), John W. Mellors (University of Pittsburgh, Pittsburgh,
PA), James Neaton (University of Minnesota, Minneapolis, MN), Sallie
Perryman (New York State Department of Health, New York, NY), John
Phair (Northwestern University, Chicago, IL), Robert T. Schooley
(University of Colorado, Denver, CO), Renslow Sherer
(The CORE Center, Cook County Hospital, Chicago, IL), Stephen
A. Spector (University of California San Diego, La Jolla, CA), Sharilyn
K. Stanley (Texas Department Of Health, Austin, TX), Paul Volberding
(University of California, San Francisco, CA), Suzanne
Willard (MCP Hahnemann University, Philadelphia, PA); participants
from the Department of Health and Human Services: Victoria Cargill
(National Institutes of Health), Mark Dybul
(National Institutes of Health), T. Randolph Graydon (Health
Care Financing Administration), Heidi Jolson (Food and Drug Administration),
Jonathan Kaplan (Centers for Disease Control and Prevention), Abe
Macher (Health Resources and Services Administration), Henry Masur
(National Institutes of Health), Lynne Mofenson (National Institutes
of Health), Jeffrey Murray (Food and Drug Administration), Joseph
O'Neill (Health Resources and Services Administration), Alice Pau
(National Institutes of Health), Lucille C. Perez (Substance Abuse
and Mental Health Services Administration), Steve Piscitelli (National
Institutes of Health). Non-voting observers include: Gerry
Bally (Health Canada, Ottawa, Ontario), Douglas
Brust (National Institutes of Health), Sophia Chang (Center
for Quality HIV Care, V.A., Palo Alto, CA), Jeffrey Jacobs (AIDS
Action Council, Washington, DC), Richard Marlink (Harvard AIDS Institute,
Cambridge, MA), Celia Maxwell (AIDS Education and Training Center,
Washington, DC), Howard Minkoff (Maimonides Medical Center, Brooklyn,
NY), James Oleske (UMDNJ, Newark, NJ), Daniel Simpson (Indian Health
Service, Rockville, MD).
|
|
html
pdf
selected tables
panel members